Stenocare Statistics

Total Valuation

Stenocare has a market cap or net worth of DKK 23.99 million. The enterprise value is 20.89 million.

Market Cap	23.99M
Enterprise Value	20.89M

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Stenocare has 38.20 million shares outstanding. The number of shares has increased by 33.54% in one year.

Current Share Class	38.20M
Shares Outstanding	38.20M
Shares Change (YoY)	+33.54%
Shares Change (QoQ)	+90.00%
Owned by Insiders (%)	4.38%
Owned by Institutions (%)	n/a
Float	25.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.90
PB Ratio	9.86
P/TBV Ratio	9.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.64
EV / Sales	11.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.97

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 1.17.

Current Ratio	1.72
Quick Ratio	1.49
Debt / Equity	1.17
Debt / EBITDA	n/a
Debt / FCF	-0.41
Interest Coverage	-24.52

Financial Efficiency

Return on equity (ROE) is -266.78% and return on invested capital (ROIC) is -95.27%.

Return on Equity (ROE)	-266.78%
Return on Assets (ROA)	-81.46%
Return on Invested Capital (ROIC)	-95.27%
Return on Capital Employed (ROCE)	-660.40%
Revenue Per Employee	232,428
Profits Per Employee	-4.10M
Employee Count	8
Asset Turnover	0.09
Inventory Turnover	44.18

Taxes

In the past 12 months, Stenocare has paid 141,671 in taxes.

Income Tax	141,671
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -84.30% in the last 52 weeks. The beta is 0.25, so Stenocare's price volatility has been lower than the market average.

Beta (5Y)	0.25
52-Week Price Change	-84.30%
50-Day Moving Average	0.39
200-Day Moving Average	1.09
Relative Strength Index (RSI)	85.16
Average Volume (20 Days)	137,939

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stenocare had revenue of DKK 1.86 million and -32.78 million in losses. Loss per share was -1.35.

Revenue	1.86M
Gross Profit	-18.34M
Operating Income	-26.12M
Pretax Income	-32.64M
Net Income	-32.78M
EBITDA	-23.56M
EBIT	-26.12M
Loss Per Share	-1.35

Full Income Statement

Balance Sheet

The company has 5.94 million in cash and 2.84 million in debt, giving a net cash position of 3.10 million or 0.08 per share.

Cash & Cash Equivalents	5.94M
Total Debt	2.84M
Net Cash	3.10M
Net Cash Per Share	0.08
Equity (Book Value)	2.43M
Book Value Per Share	0.06
Working Capital	3.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.98 million and capital expenditures -44,412, giving a free cash flow of -7.02 million.

Operating Cash Flow	-6.98M
Capital Expenditures	-44,412
Free Cash Flow	-7.02M
FCF Per Share	-0.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,404.58%
Pretax Margin	-1,755.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Stenocare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.54%
Shareholder Yield	n/a
Earnings Yield	-136.66%
FCF Yield	-29.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stenocare has an Altman Z-Score of -4.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.38
Piotroski F-Score	2